close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LeonaBio, Inc. - Common Stock (NQ:LONA)

7.570 -0.260 (-3.32%)
Streaming Delayed Price Updated: 1:26 PM EDT, Aug 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,756
Open 7.950
Bid (Size) 7.200 (300)
Ask (Size) 8.500 (300)
Prev. Close 7.830
Today's Range 7.570 - 8.110
52wk Range 4.210 - 14.21
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
On Track to Complete Enrollment of the Phase 3 ELAINE-3 clinical trial in 4Q 2026 with Topline Data Expected in 2H 2027 
From LeonaBio, Inc.
Via GlobeNewswire

Performance

YTD
+15.6%
+15.6%
1 Month
N/A
N/A
3 Month
-21.3%
-21.3%
6 Month
+59.0%
+59.0%
1 Year
+15.6%
+15.6%

More News

Read More
News headline image
LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
From LeonaBio, Inc.
Via GlobeNewswire
LeonaBio (NASDAQ:LONA) Beats Q1 Loss Estimates as Phase 3 Breast Cancer Trial Enrollment Expands ↗
Via Chartmill
News headline image
LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer
From LeonaBio, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is LeonaBio, Inc. - Common Stock publicly traded?
Yes, LeonaBio, Inc. - Common Stock is publicly traded.
What exchange does LeonaBio, Inc. - Common Stock trade on?
LeonaBio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for LeonaBio, Inc. - Common Stock?
The ticker symbol for LeonaBio, Inc. - Common Stock is LONA on the Nasdaq Stock Market
What is the current price of LeonaBio, Inc. - Common Stock?
The current price of LeonaBio, Inc. - Common Stock is 7.570
When was LeonaBio, Inc. - Common Stock last traded?
The last trade of LeonaBio, Inc. - Common Stock was at 08/20/26 01:26 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.